{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T06:35:14Z","timestamp":1794897314392,"version":"4.9.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002402","name":"Sun Yat-sen University","doi-asserted-by":"publisher","award":["23qnpy125"],"award-info":[{"award-number":["23qnpy125"]}],"id":[{"id":"10.13039\/501100002402","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009334","name":"Pearl River S and T Nova Program of Guangzhou","doi-asserted-by":"publisher","award":["2021QN02Y220"],"award-info":[{"award-number":["2021QN02Y220"]}],"id":[{"id":"10.13039\/501100009334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["JCYJ20210324124602005"],"award-info":[{"award-number":["JCYJ20210324124602005"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NSFC 82104079"],"award-info":[{"award-number":["NSFC 82104079"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015805","name":"Shenzhen Municipal Science and Technology Innovation Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015805","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.biomaterials.2025.123516","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:59:24Z","timestamp":1750208364000},"page":"123516","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Bone marrow microenvironment-responsive polymeric-drug\/siRNA regulates leukemia stem cells assisting for prevention of AML relapse"],"prefix":"10.1016","volume":"324","author":[{"given":"Shihong","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqiu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianing","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chujie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9759-2417","authenticated-orcid":false,"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2025.123516_bib1","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1038\/s41591-024-03271-5","article-title":"Cytokine-mediated CAR T therapy resistance in AML","volume":"30","author":"Bhagwat","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.biomaterials.2025.123516_bib2","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa1716863","article-title":"Molecular minimal residual disease in acute myeloid leukemia","volume":"378","author":"Mauvieux","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biomaterials.2025.123516_bib3","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1158\/2159-8290.CD-20-1375","article-title":"Chemotherapy induces senescence-like resilient cells capable of initiating AML recurrence","volume":"11","author":"Duy","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.biomaterials.2025.123516_bib4","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1182\/blood.2019001982","article-title":"How I treat relapsed or refractory AML","volume":"136","author":"DeWolf","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.biomaterials.2025.123516_bib5","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.3390\/cancers14051241","article-title":"Emerging CAR T cell strategies for the treatment of AML","volume":"14","author":"Vishwasrao","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.biomaterials.2025.123516_bib6","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000937","article-title":"CAR-T in the treatment of acute myeloid leukemia: barriers and how to overcome them","volume":"7","author":"Vanhooren","year":"2023","journal-title":"Hemasphere"},{"key":"10.1016\/j.biomaterials.2025.123516_bib7","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.3390\/cancers15102713","article-title":"The black hole: CAR T cell therapy in AML","volume":"15","author":"Atilla","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.biomaterials.2025.123516_bib8","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.3390\/cancers15112944","article-title":"CAR-T cells immunotherapies for the treatment of acute myeloid leukemia-recent advances","volume":"15","author":"Zarychta","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.biomaterials.2025.123516_bib9","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(23)00108-3","article-title":"Acute myeloid leukaemia","volume":"401","author":"Dinardo","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.biomaterials.2025.123516_bib10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13045-023-01424-6","article-title":"Recent advances in targeted therapies in acute myeloid leukemia","volume":"16","author":"Bhansali","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.biomaterials.2025.123516_bib11","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41568-019-0230-9","article-title":"The leukaemia stem cell: similarities, differences and clinical prospects in CML and AML","volume":"20","author":"Vetrie","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biomaterials.2025.123516_bib12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12943-016-0571-x","article-title":"Targeting acute myeloid leukemia stem cell signaling by natural products","volume":"16","author":"Siveen","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biomaterials.2025.123516_bib13","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1182\/blood.V128.22.1544.1544","article-title":"Early and late leukemic stem cells in murine leukemia models","volume":"128","author":"Dong","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.biomaterials.2025.123516_bib14","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/joim.13236","article-title":"The evolution of leukaemia from pre-leukaemic and leukaemic stem cells","volume":"289","author":"Shlush","year":"2021","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.biomaterials.2025.123516_bib15","doi-asserted-by":"crossref","first-page":"17ra9","DOI":"10.1126\/scitranslmed.3000349","article-title":"Identification of therapeutic targets for quiescent, chemotherapy-resistant human leukemia stem cells","volume":"2","author":"Saito","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biomaterials.2025.123516_bib16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s40164-021-00233-2","article-title":"Leukemia stem cell-bone marrow microenvironment interplay in acute myeloid leukemia development","volume":"10","author":"Yao","year":"2021","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.biomaterials.2025.123516_bib17","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.blre.2017.03.004","article-title":"The bone marrow microenvironment - home of the leukemic blasts","volume":"31","author":"Shafat","year":"2017","journal-title":"Blood Rev."},{"key":"10.1016\/j.biomaterials.2025.123516_bib18","doi-asserted-by":"crossref","first-page":"29144","DOI":"10.1073\/pnas.2013319117","article-title":"Advanced fluorescence microscopy reveals disruption of dynamic CXCR4 dimerization by subpocket-specific inverse agonists","volume":"117","author":"I\u015fbilir","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biomaterials.2025.123516_bib19","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1182\/blood-2019-130029","article-title":"Deregulated CXCR4-CXCL12 signaling impacts on the pathogenesis of DLBCL","volume":"134","author":"Pansy","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.biomaterials.2025.123516_bib20","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1182\/blood-2020-142619","article-title":"CXCR4 signaling in AML is dampened by the endogenous CXCR4 inhibitory peptide EPI-X4","volume":"136","author":"Kaiser","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.biomaterials.2025.123516_bib21","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.gendis.2023.01.008","article-title":"Signaling pathways governing the behaviors of leukemia stem cells","volume":"11","author":"Azizidoost","year":"2024","journal-title":"Genes. Dis."},{"key":"10.1016\/j.biomaterials.2025.123516_bib22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.stem.2016.06.001","article-title":"Leukemic stem cells evade chemotherapy by metabolic adaptation to an adipose tissue niche","volume":"19","author":"Ye","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.biomaterials.2025.123516_bib23","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1158\/1078-0432.CCR-12-2333","article-title":"BMS-936564\/MDX-1338: a fully human Anti-CXCR4 antibody induces apoptosis and shows antitumor activity in hematologic malignancies","volume":"19","author":"Kuhne","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biomaterials.2025.123516_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202001890","article-title":"Synthetic CXCR4 antagonistic peptide assembling with nanoscaled micelles combat acute myeloid leukemia","volume":"16","author":"Meng","year":"2020","journal-title":"Small"},{"key":"10.1016\/j.biomaterials.2025.123516_bib25","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1182\/blood.V128.22.4055.4055","article-title":"Peptide-Receptor radiotherapy with CXCR4-Targeting pentixather reduces leukemia burden in acute leukemia PDX and patients","volume":"128","author":"Habringer","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.biomaterials.2025.123516_bib26","doi-asserted-by":"crossref","first-page":"6206","DOI":"10.1182\/blood-2008-06-162123","article-title":"Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100","volume":"113","author":"Nervi","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.biomaterials.2025.123516_bib27","doi-asserted-by":"crossref","first-page":"8740","DOI":"10.1002\/anie.201203463","article-title":"Dual-Function CXCR4 antagonist polyplexes to deliver gene therapy and inhibit cancer cell invasion","volume":"51","author":"Li","year":"2012","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.biomaterials.2025.123516_bib28","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.3324\/haematol.2017.183418","article-title":"Phase I trial of plerixafor combined with decitabine in newly diagnosed older patients with acute myeloid leukemia","volume":"103","author":"Roboz","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.biomaterials.2025.123516_bib29","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1182\/blood-2019-130956","article-title":"Characterization of leukemic stem cells heterogeneity in chronic Myeloid leukemia","volume":"134","author":"Warfvinge","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.biomaterials.2025.123516_bib30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.semcancer.2019.07.015","article-title":"The emerging, multifaceted role of mitophagy in cancer and cancer therapeutics","volume":"66","author":"Panigrahi","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.biomaterials.2025.123516_bib31","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1182\/blood-2019-127024","article-title":"Mitophagy plays a key role in the anti-leukemic activity of autophagy inhibitors under hypoxia in Acute myeloid leukemia","volume":"134","author":"Fay","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.biomaterials.2025.123516_bib32","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood.V128.22.1703.1703","article-title":"Mitochondrial Fission 1 regulates GSK3 and AMPK signaling to sustain leukemia stem cell function in acute myelogenous leukemia","volume":"128","author":"Pei","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.biomaterials.2025.123516_bib33","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1182\/blood.V126.23.842.842","article-title":"Regulation of mitochondrial morphology is important for leukemia stem cell function","volume":"126","author":"Pei","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.biomaterials.2025.123516_bib34","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.stem.2018.05.021","article-title":"AMPK\/FIS1-Mediated mitophagy is required for self-renewal of human AML stem cells","volume":"23","author":"Pei","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.biomaterials.2025.123516_bib35","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1080\/15548627.2020.1822628","article-title":"The role of autophagy in targeted therapy for acute myeloid leukemia","volume":"17","author":"Du","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.biomaterials.2025.123516_bib36","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1182\/blood.2021014670","article-title":"Single-cell genomics in AML: extending the frontiers of AML research","volume":"141","author":"Ediriwickrema","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.biomaterials.2025.123516_bib37","first-page":"2059","article-title":"STX17 dynamically regulated by Fis1 induces mitophagy via hierarchical macroautophagic mechanism (vol 10, 2059, 2019)","volume":"12","author":"Xian","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2025.123516_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-022-01683-4","article-title":"Bone marrow-targetable Green Tea Catechin-based micellar nanocomplex for synergistic therapy of Acute myeloid leukemia","volume":"20","author":"Bae","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.biomaterials.2025.123516_bib39","first-page":"499","article-title":"Transferrin-guided intelligent nanovesicles augment the targetability and potency of clinical PLK1 inhibitor to acute myeloid leukemia","volume":"21","author":"Xia","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.biomaterials.2025.123516_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2021.101106","article-title":"FeO@Pt nanozymes combining with CXCR4 antagonists to synergistically treat acute myeloid leukemia","volume":"37","author":"Kong","year":"2021","journal-title":"Nano Today"},{"key":"10.1016\/j.biomaterials.2025.123516_bib41","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1182\/blood-2017-12-784132","article-title":"The interplay of leukemia cells and the bone marrow microenvironment","volume":"131","author":"Duarte","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.biomaterials.2025.123516_bib42","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/s41467-022-27973-x","article-title":"Quantification of bone marrow interstitial pH and calcium concentration by intravital ratiometric imaging","volume":"13","author":"Yeh","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2025.123516_bib43","first-page":"1213","article-title":"The essential roles of TIMP-2, MT1-MMP, and MMP-2 in the invasive capacity of SHI-1 leukemic cells","volume":"114","author":"Wang","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.biomaterials.2025.123516_bib44","doi-asserted-by":"crossref","first-page":"396a","DOI":"10.1182\/blood.V106.11.1368.1368","article-title":"Stem cell mobilization and egress of AML blasts from the bone marrow are both regulated by MT-MMP-mediated activation of MMP-2","volume":"106","author":"Marquez-Curtis","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.biomaterials.2025.123516_bib45","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.biomaterials.2017.10.053","article-title":"Development of PEGylated aspartic acid-modified liposome as a bone-targeting carrier for the delivery of paclitaxel and treatment of bone metastasis","volume":"154","author":"Yamashita","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2025.123516_bib46","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.1016\/j.actbio.2014.07.015","article-title":"Aspartic acid-based modified PLGA-PEG nanoparticles for bone targeting: in vitro and in vivo evaluation","volume":"10","author":"Fu","year":"2014","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biomaterials.2025.123516_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120404","article-title":"Targeting nanoparticles for diagnosis and therapy of bone tumors: opportunities and challenges","volume":"265","author":"Gao","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2025.123516_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202000309","article-title":"Biomimetic, hypoxia-responsive nanoparticles overcome residual chemoresistant leukemic cells with Co-Targeting of therapy-induced bone marrow niches","volume":"30","author":"Dong","year":"2020","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biomaterials.2025.123516_bib49","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1182\/blood.V118.21.1410.1410","article-title":"Chemotherapy-Induced CXCR4 modulation predicts the efficacy of Plerixafor as a chemosensitizer in acute leukemia","volume":"118","author":"Sison","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.biomaterials.2025.123516_bib50","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/jat.3749","article-title":"The use of cobalt chloride as a chemical hypoxia model","volume":"39","author":"Mu\u00f1oz-S\u00e1nchez","year":"2019","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.biomaterials.2025.123516_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121562","article-title":"Modified chitosan for effective renal delivery of siRNA to treat acute kidney injury","volume":"285","author":"Tang","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2025.123516_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122707","article-title":"Astroglial membrane camouflaged Ptbp1 siRNA delivery hinders glutamate homeostasis via SDH\/Nrf2 pathway","volume":"312","author":"Liu","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2025.123516_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119760","article-title":"Redox-responsive polyprodrug nanoparticles for targeted siRNA delivery and synergistic liver cancer therapy","volume":"234","author":"Li","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2025.123516_bib54","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13045-017-0532-x","article-title":"An improved pre-clinical patient-derived liquid xenograft mouse model for acute myeloid leukemia","volume":"10","author":"Her","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.biomaterials.2025.123516_bib55","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1182\/blood.V128.22.2833.2833","article-title":"Targeting innate and adaptive immune responses for the treatment of Acute Myeloid leukemia","volume":"128","author":"Przespolewski","year":"2016","journal-title":"Blood"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225004351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225004351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T13:40:53Z","timestamp":1778766053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961225004351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":55,"alternative-id":["S0142961225004351"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123516","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone marrow microenvironment-responsive polymeric-drug\/siRNA regulates leukemia stem cells assisting for prevention of AML relapse","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123516","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123516"}}